Cardiax is a health analytics tool for the detection of genetic polymorphisms associated with cardiovascular disease, hypertension, diabetes, insulin resistance, atrial fibrillation, stroke and dyslipidemia. CardiaX aims to reduce the prevalence of heart disease and associated conditions by empowering patients and physicians with a vital resource for early risk detection and an enhanced focus on personalized primary prevention. CardiaX is the largest collection of genetic mutations and serological tests that provides potential risks for heart, metabolic, and vascular conditions for individuals with the following risks:

  • Family history of heart disease
  • Uncontrolled hypertension
  • History of cardiac events
  • Diagnosed with metabolic syndrome
  • Elevated inflammatory markers
  • Increased medical risk for hypertension

CardiaX may be an appropriate test to run if you have or are suspected of having any of the following symptoms or conditions:

  • Plaque rupture
  • Coronary artery disease
  • Myocardial infarction
  • Diabetes mellitus
  • Insulin resistance
  • Venous thrombosis
  • Atrial fibrillation
  • Cardiovascular disease
  • Tachycardia
  • Congestive heart failure
  • Obesity
  • Dyslipidemia
  • Ischemic stroke
  • Hypertension
  • Endothelial dysfunction

Not Available in New York state

Only healthcare providers licensed in their state may order laboratory testing. Regulatory Statement Vibrant testing does not demonstrate absolute positive and negative predictive values for any disease state or condition. Its clinical utility has not been fully established. Vibrant validates the accuracy and precision of the testing but not of its clinical or diagnostic value. So these tests are for wellness and informational purpose only. Vibrant is actively doing clinical research on these samples, de-identified from patients under an IRB, and will make research publications towards the same as and when the clinical utility is well established. These tests have been laboratory developed and their performance characteristics determined by Vibrant America LLC, a CLIA-certified laboratory performing the test CLIA#:05D2078809. The test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. The general wellness test intended uses relate to sustaining or offering general improvement to functions associated with a general state of health while making reference to diseases or conditions. Content provided for informational purposes only and should not be construed as medical advice. Content provided to help you make healthy lifestyle, dietary, and treatment choices in consultation with your healthcare provider. It is intended to be used as a tool to encourage a general state of health and well-being. Please consult with your healthcare practitioner for diagnosis and treatment considerations. The Vibrant Wellness platform provides tools for you to track and analyze your general wellness profile.